Neil Stahl - Net Worth and Insider Trading
Neil Stahl Net Worth
The estimated net worth of Neil Stahl is at least $46 Million dollars as of 2024-12-03. Neil Stahl is the EVP Research and Development of Regeneron Pharmaceuticals Inc and owns about 60,553 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $46 Million. Details can be seen in Neil Stahl's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Neil Stahl has not made any transactions after 2024-08-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Neil Stahl
Neil Stahl Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Neil Stahl owns 1 companies in total, including Regeneron Pharmaceuticals Inc (REGN) .
Click here to see the complete history of Neil Stahl’s form 4 insider trades.
Insider Ownership Summary of Neil Stahl
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2024-08-08 | SVP & Preclinical Development |
Neil Stahl Latest Holdings Summary
Neil Stahl currently owns a total of 1 stock. Neil Stahl owns 60,553 shares of Regeneron Pharmaceuticals Inc (REGN) as of August 8, 2024, with a value of $46 Million.
Latest Holdings of Neil Stahl
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2024-08-08 | 60,553 | 762.34 | 46,161,974 |
Holding Weightings of Neil Stahl
Neil Stahl Form 4 Trading Tracker
According to the SEC Form 4 filings, Neil Stahl has made a total of 8 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 5,197 shares on August 8, 2024, which brought Neil Stahl around $6 Million.
Insider Trading History of Neil Stahl
- 1
Neil Stahl Trading Performance
Neil Stahl Ownership Network
Neil Stahl Owned Company Details
What does Regeneron Pharmaceuticals Inc do?
Who are the key executives at Regeneron Pharmaceuticals Inc?
Neil Stahl is the SVP & Preclinical Development of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , VP & Controller Christopher R. Fenimore , and EVP Research Andrew J Murphy .
Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary
Over the past 18 months, Neil Stahl made 3 insider transaction in Regeneron Pharmaceuticals Inc (REGN) with a net sale of 24,899. Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 10,564 shares made by Marion Mccourt , a net sale of 1,400 shares made by Arthur F Ryan , and a net sale of 7,918 shares made by Bonnie L Bassler .
In summary, during the past 3 months, insiders sold 2,100 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 2,100 shares. During the past 18 months, 315,669 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,669 shares.
Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regeneron Pharmaceuticals Inc Insider Transactions
Neil Stahl Mailing Address
Above is the net worth, insider trading, and ownership report for Neil Stahl. You might contact Neil Stahl via mailing address: 777 Old Saw Mill River Road, Tarrytown Ny 10591.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
